Clinical Trials Logo

Clinical Trial Summary

Atherosclerosis is unquestionably the leading cause of morbidity and mortality in developed countries, and the world-wide importance of acute vascular syndromes is increasing. Rupture of atherosclerotic plaque has been identified as the proximate event in the majority of cases of acute ischemic syndromes. Therefore, modalities capable of characterizing the atherosclerotic lesion may be helpful in understanding its natural history and detecting lesions with high risk for acute events.

Optical coherence tomography (OCT) is a powerful tool capable of tomographic imaging based on low coherence interferometry. It is analogous to ultrasound imaging except that it uses infrared light instead of sound. Polarization-sensitive optical coherence tomography (PS-OCT) combines the advantages of OCT with additional image contrast of the sample. The added contrast is based on the ability of PS-OCT to detect the birefringent properties of a sample (phase retardation and fast-axis orientation) simultaneously.

The goals of this project are: 1) to examine whether PS-OCT is an acceptable tool for the characterization of typical plaque constituents; and 2) to explain the correlation between birefringence and forming or rupture of a plaque; and 3) to establish a quantitative PS-OCT image criteria for atherosclerotic plaque characterization in vitro.


Clinical Trial Description

Optical Coherence Tomography (OCT) is a promising new class of diagnostic medical imaging technology that utilizes advanced photonics and fiber optics to obtain images and tissue characterization on a scale never before possible within the human body. OCT combines the principles of ultrasound with the imaging performance of a microscope and a form factor that is familiar to clinicians. Whereas ultrasound produces images from backscattered sound "echoes," OCT uses infrared light waves that reflect off the internal microstructure within the biological tissues. ;


Study Design

Observational Model: Case Control, Primary Purpose: Screening, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms

  • Pathological Conditions, Anatomical

NCT number NCT00173238
Study type Observational
Source National Taiwan University Hospital
Contact Nai-Kuan Chou, MD.,PhD
Phone 886-2-23123456
Email nickchou@ha.mc.ntu.edu.tw
Status Recruiting
Phase N/A
Start date June 2005
Completion date June 2008

See also
  Status Clinical Trial Phase
Completed NCT02602223 - Comparison of Amnion Chorion Membrane vs. Dense Polytetrafluoroethylene Membrane in Ridge Preservation Procedures Phase 2
Completed NCT06034652 - T-GENVIH-003 LTFU (Long Term Follow Up) Study
Terminated NCT02351726 - Mitroflow DL Post Approval Study- North America N/A
Completed NCT02875860 - 'TOTAL' (Tracheal Occlusion To Accelerate Lung Growth) Trial Phase 2
Recruiting NCT05723198 - A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata Phase 3
Completed NCT02905344 - Effectiveness of Using 3D Printed Models to Educate Otolaryngology (Ear, Nose, Nose and Throat (ENT)) Patients About Surgery: A Survey N/A
Completed NCT03072472 - BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities N/A
Not yet recruiting NCT04922528 - Visualization of the Extrahepatic biliaRy Tree Trial N/A
Completed NCT01343667 - GORE Flow Reversal System and GORE Embolic Filter Extension Study N/A
Recruiting NCT05810272 - Impact of Postprandial 'Exercise Snacks' on Protein and Glucose Metabolism Following a Period of Step Reduction in Older Adults N/A